Chesapeake Urology Associates (CUA) P.A. — Towson, Maryland

Chesapeake Urology Associates (CUA) P.A. is a clinical research site located in Towson, Maryland, United States 21204.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Chesapeake Urology Associates (CUA) P.A. has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Metastatic Castration-Resistant Prostate Cancer, Prostate Cancer.

Sponsors: POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company, Endocyte.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Chesapeake Urology Associates (CUA) P.A.?

Chesapeake Urology Associates (CUA) P.A. has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Chesapeake Urology Associates (CUA) P.A. conducted?

Chesapeake Urology Associates (CUA) P.A. has 2 clinical trials on record, with 1 currently active. Their work covers Metastatic Castration-Resistant Prostate Cancer, Prostate Cancer.

Is Chesapeake Urology Associates (CUA) P.A. accredited by Crixeo Health?

Chesapeake Urology Associates (CUA) P.A. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Chesapeake Urology Associates (CUA) P.A.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.